CANZUVRA
Live / Applied — Extension of time to oppose received (as of 24 Aug 2026)
What this means for you
Not registered yet, but its 07 Apr 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99749403
- Mark type
- Word mark
- Filed
- 07 Apr 2026
- Published for opposition
- 28 Jul 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, viral immunotherapies for the treatment of prostate, lung, brain, and pancreatic cancers, and solid tumors
Owner
- Candel Therapeutics, Inc., Needham, MA, US
- Candel Therapeutics, Inc., Needham, MA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 99749403 — MERCK SHARP & DOHME LLC v. Candel Therapeutics, Inc., filed 24 Aug 2026 (Open)
Prosecution history
- 24 Aug 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 28 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jul 2026 — PUBLISHED FOR OPPOSITION
- 22 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jun 2026 — ASSIGNED TO EXAMINER
- 07 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 07 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Apr 2026 — NEW APPLICATION ENTERED